Skip to main content

Table 7 Changes of Quality of Life in Patients with Successful CTO-PCI SF-12 during follow-up in each group

From: Benefits of successful percutaneous coronary intervention in chronic total occlusion patients with diabetes

 

PCS

MCS

No Diabetes

 Baseline

44.73 ± 8.11

53.96 ± 6.95

 1 month follow-up

50.42 ± 6.13

56.24 ± 4.69

 1 year follow-up

51.07 ± 6.54

54.75 ± 6.80

 mΔ

5.53 ± 9.99

2.28 ± 7.93

 yΔ

6.34 ± 10.22

0.64 ± 9.47

 mp Value

 < 0.001

 < 0.001

 yp Value

 < 0.001

0.081

Diabetes

 Baseline

44.00 ± 8.44

54.50 ± 7.29

 1 month follow-up

50.16 ± 7.06

55.51 ± 1.52

 1 year follow-up

51.07 ± 6.54

54.16 ± 6.78

 mΔ

5.92 ± 10.15

1.13 ± 8.19

 yΔ

7.19 ± 10.28

-0.29 ± 10.54

 mp Value

 < 0.001

0.015

 yp Value

 < 0.001

0.722

 ap Value

0.576

0.038

 bp Value

0.257

0.197

  1. CTO chronic total occlusion, PCI percutaneous coronary intervention, PCS physical functioning component score, MCS mental functioning component score
  2. mΔ change between baseline and 1 month follow-up
  3. yΔ change between baseline and 1 year follow-up
  4. mp Value: baseline versus 1 month follow-up
  5. yp Value: baseline versus 1 year follow-up
  6. ap Value: comparison of mΔ in the two groups
  7. bp Value: comparison of yΔ in the two groups